FDA Requests Public Comment on Proposed Collection of Information for Fast Track Drug Development Programs

Summary

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to fast track drug development programs, which are designed to expedite the review process for new drugs and biologics.